US2009142803A1PendingUtilityA1
Amylolytic Enzyme Variants
Est. expiryFeb 27, 2018(expired)· nominal 20-yr term from priority
C12N 9/2417A21D 8/042
70
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The inventors have discovered some striking, and not previously predicted structural similarities and differences between the structure of Novamyl and the reported structures of CGTases, and based on this they have constructed variants of maltogenic alpha-amylase having CGTase activity and variants of CGTase having maltogenic alpha-amylase activity. Further, on the basis of sequence homology between Novamyl® and CGTases, the inventors have constructed hybrid enzymes with one or more improvements to specific properties of the parent enzymes, using recombinant DNA methodology.
Claims
exact text as granted — not AI-modified1 . A method for producing a variant of a parent cyclodextrin glucanotransferase, comprising modifying the amino acid sequence of a parent cyclodextrin glucanotransferase by substituting, inserting or deleting one or more amino acids of said amino acid sequence, wherein said substitution is a substitution an amino acid residue which is present in a corresponding position in the amino acid sequence of amino acids 1 to 686 of SEQ ID NO:1 but which is not present in the amino acid sequence of the parent cyclodextrin glucanotransferase; wherein said insertion is an insertion of an amino acid residue which is present in a corresponding position in the amino acid sequence of amino acids 1 to 686 of SEQ ID NO:1 but which is not present in the amino acid sequence of the parent cyclodextrin glucanotransferase; and wherein said deletion is a deletion of an amino acid residue which is present in the parent cyclodextrin glucanotransferase but which is not present in the amino acid sequence of amino acids 1 to 686 of SEQ ID NO:1, and wherein the cyclodextrin glucanotransferase variant forms linear oligosaccharides when acting on starch.
2 . The method of claim 1 , wherein the parent cyclodextrin glucanotransferase is from a strain of Bacillus.
3 . The method of claim 1 , wherein the parent cyclodextrin glucanotransferase is from a strain of Brevibacterium.
4 . The method of claim 1 , wherein the parent cyclodextrin glucanotransferase variant is from a strain of Clostridium.
5 . The method of claim 1 , wherein the parent cyclodextrin glucanotransferase variant is from a strain of Corynebacterium.
6 . The method of claim 1 , wherein the parent cyclodextrin glucanotransferase variant is from a strain of Klebsiella.
7 . The method of claim 1 , wherein the parent cyclodextrin glucanotransferase variant is from a strain of Micrococcus.
8 . The method of claim 1 , wherein the parent cyclodextrin glucanotransferase variant is from a strain of Thermoanaerobacter
9 . The method of claim 1 , wherein the parent cyclodextrin glucanotransferase variant is from a strain of Thermoanaerobacterium.
10 . A cyclodextrin glucanotransferase variant prepared by the method of claim 1 .
11 . A method for producing a variant of a parent cyclodextrin glucanotransferase, comprising
(a) modifying the amino acid sequence of a parent cyclodextrin glucanotransferase by substituting, inserting or deleting one or more amino acids of said amino acid sequence, wherein said substitution is a substitution an amino acid residue which is present in a corresponding position in the amino acid sequence of amino acids 1 to 686 of SEQ ID NO:1 but which is not present in the amino acid sequence of the parent cyclodextrin glucanotransferase; wherein said insertion is an insertion of an amino acid residue which is present in a corresponding position in the amino acid sequence of amino acids 1 to 686 of SEQ ID NO:1 but which is not present in the amino acid sequence of the parent cyclodextrin glucanotransferase; and wherein said deletion is a deletion of an amino acid residue which is present in the parent cyclodextrin glucanotransferase but which is not present in the amino acid sequence of amino acids 1 to 686 of SEQ ID NO:1, (b) testing the variant cyclodextrin glucanotransferase for the ability to form linear oligosaccharides when acting on starch; (c) producing the variant cyclodextrin glucanotransferase by cultivating a host cell comprising a nucleic acid sequence encoding the variant cyclodextrin glucanotransferase; and (d) recovering the cyclodextrin glucanotransferase variant.
12 . A method for producing a variant of a parent cyclodextrin glucanotransferase, comprising:
(a) cultivating a host cell comprising a nucleic acid sequence encoding a variant of a cyclodextrin glucanotransferase, wherein said cyclodextrin glucanotransferase variant comprises and insertion, substitution or deletion of one or more amino acids, wherein said substitution is a substitution an amino acid residue which is present in a corresponding position in the amino acid sequence of amino acids 1 to 686 of SEQ ID NO:1 but which is not present in the amino acid sequence of the parent cyclodextrin glucanotransferase; wherein said insertion is an insertion of an amino acid residue which is present in a corresponding position in the amino acid sequence of amino acids 1 to 686 of SEQ ID NO:1 but which is not present in the amino acid sequence of the parent cyclodextrin glucanotransferase; and wherein said deletion is a deletion of an amino acid residue which is present in the parent cyclodextrin glucanotransferase but which is not present in the amino acid sequence of amino acids 1 to 686 of SEQ ID NO:1, and wherein the cyclodextrin glucanotransferase variant forms linear oligosaccharides when acting on starch. (b) recovering the cyclodextrin glucanotransferase variant.
13 . The method of claim 12 , wherein the cyclodextrin glucanotransferase is derived from a strain of Bacillus, Brevibacterium, Clostridium, Corynebacterium, Klebsiella, Micrococcus, Thermoanaerobacter or Thermoanaerobacterium.
14 . A cyclodextrin glucanotransferase variant prepared by the method of claim 12 .
15 . A method for producing a variant of a parent cyclodextrin glucanotransferase, comprising:
(a) cultivating a host cell comprising a nucleic acid sequence encoding a variant of a cyclodextrin glucanotransferase, wherein said cyclodextrin glucanotransferase variant comprises and insertion, substitution or deletion of one or more amino acids, wherein said substitution is a substitution an amino acid residue which is present in a corresponding position in the amino acid sequence of amino acids 1 to 686 of SEQ ID NO:1 but which is not present in the amino acid sequence of the parent cyclodextrin glucanotransferase; wherein said insertion is an insertion of an amino acid residue which is present in a corresponding position in the amino acid sequence of amino acids 1 to 686 of SEQ ID NO:1 but which is not present in the amino acid sequence of the parent cyclodextrin glucanotransferase; and wherein said deletion is a deletion of an amino acid residue which is present in the parent cyclodextrin glucanotransferase but which is not present in the amino acid sequence of amino acids 1 to 686 of SEQ ID NO:1; (b) transforming a host cell with the nucleic acid sequence encoding the variant; (c) cultivating the transformed host cell to express the variant; (d) testing the variant cyclodextrin glucanotransferase for the ability to form linear oligosaccharides when acting on starch; (e) producing the variant cyclodextrin glucanotransferase by cultivating a host cell comprising a nucleic acid sequence encoding the variant cyclodextrin glucanotransferase; (f) recovering the cyclodextrin glucanotransferase variant.Join the waitlist — get patent alerts
Track US2009142803A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.